Washington D.C., DC3 Active Studies

Peripheral Artery Disease Clinical Trials in Washington D.C., DC

Find 3 actively recruiting peripheral artery disease clinical trials in Washington D.C., DC. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
5,910
Enrolling

Recruiting Peripheral Artery Disease Studies in Washington D.C.

About Peripheral Artery Disease Clinical Trials in Washington D.C.

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 3 peripheral artery disease clinical trials recruiting participants in Washington D.C., DC. These studies are seeking a combined 5,910 participants. Research is being sponsored by Boston Scientific Corporation, Cagent Vascular LLC, Cook Research Incorporated. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Washington D.C. — FAQ

Are there peripheral artery disease clinical trials in Washington D.C.?

Yes, there are 3 peripheral artery disease clinical trials currently recruiting in Washington D.C., DC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Washington D.C.?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.C. research site will contact you about next steps.

Are clinical trials in Washington D.C. free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.C. studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 3 active trials in Washington D.C. are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated November 5, 2026 from ClinicalTrials.gov